Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

PGLAF

Progen (PGLAF)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PGLAF
DataOraFonteTitoloSimboloCompagnia
16/05/200612:53PR Newswire (US)Progen Prepares for Accelerated Clinical Development of PI-88 Following FDA MeetingNASDAQ:PGLAFProgen Industries
09/08/200513:00PR Newswire (US)Progen Expand PI-88 Clinical Development to Prostate CancerNASDAQ:PGLAF
28/06/200507:28PR Newswire (US)Progen Engages Burrill to Advance PI-88 Partnering DiscussionsNASDAQ:PGLAF
17/05/200506:14PR Newswire (US)Results of PI-88 Phase II Clinical Trial in Melanoma Presented at ASCONASDAQ:PGLAFProgen Industries
27/08/200406:53PR Newswire (US)Progen Reports Solid Financial PerformanceNASDAQ:PGLAFProgen Industries
14/07/200405:36PR Newswire (US)PI-88 Phase II Clinical Trial Targeting Liver Cancer LaunchedNASDAQ:PGLAFProgen Industries
04/05/200404:49PR Newswire (US)U.S. FDA Grants Orphan Drug Status to PI-88 for MelanomaNASDAQ:PGLAF
27/02/200412:00PR Newswire (US)Half Year Report - Progen on Track to Meet MilestonesNASDAQ:PGLAF
11/02/200405:48PR Newswire (US)Progen Commences Third PI-88 Phase II TrialNASDAQ:PGLAFProgen Industries
19/11/200304:20PR Newswire (US)Bonus Issue of Options - Record Date November 28 2003NASDAQ:PGLAFProgen Industries
11/11/200302:58PR Newswire (US)Progen Sharpens Cancer Focus Through DivestmentNASDAQ:PGLAF
31/10/200307:43PR Newswire (US)Progen Industries Limited New Placement Terms AnnouncedNASDAQ:PGLAFProgen Industries
31/10/200307:30PR Newswire (US)Progen Industries Limited Annual General MeetingNASDAQ:PGLAF
29/10/200302:42PR Newswire (US)Progen Granted Anti-Angiogenesis Antibody PatentNASDAQ:PGLAFProgen Industries
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PGLAF
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network